NCT03521557 (GPS) is a NA clinical trial of Gaze and Postural Stability in Multiple Sclerosis, sponsored by University of Utah.

Who is sponsoring NCT03521557?

NCT03521557 is sponsored by University of Utah.

What drugs are being tested in NCT03521557?

Interventions in NCT03521557: Gaze and Postural Stability, Standard Care Control.

What condition does NCT03521557 study?

NCT03521557 studies Multiple Sclerosis, Vertigo, Dizziness, Falls Injury.

Is NCT03521557 still recruiting?

NCT03521557 is currently completed. Last updated 6 October 2021.

Last reviewed 2021-10-06 · How we verify

NCT03521557: GPS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gaze and Postural Stability in Multiple Sclerosis

Completed NA Last updated 6 October 2021

What this trial tests

NA trial testing Gaze and Postural Stability in Multiple Sclerosis in 42 participants. Completed in 30 September 2020.

Timeline

29 May 2018

Primary endpoint
30 June 2020

30 September 2020

Quick facts

Lead sponsor	University of Utah
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	42
Start date	29 May 2018
Primary completion	30 June 2020
Estimated completion	30 September 2020
Sites	1 location across United States

Drugs / interventions tested

Gaze and Postural Stability
Standard Care Control

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →
Vertigo — all drugs for Vertigo →
Dizziness — all drugs for Dizziness →
Falls Injury — all drugs for Falls Injury →

Sponsor

University of Utah

Who can join

Adults 20 to 75, any sex, with Multiple Sclerosis or Vertigo. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In order to provide information that will improve therapy, the goals of this project are to determine if persons with MS with complaints of dizziness and at risk for falls can improve their balance and vision stability as a result of a bout of specific treatment. This project seeks to do this by conducting an experiment where people with MS are randomly assigned to a group that practices activities known to help improve inner ear function or a group that practices activities known to improve endurance and strength but that should not change inner ear function. Such a comparison will allow us to gain understanding of how the inner ear system is affected in MS and how it responds to treatment.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Rehabilitation to improve gaze and postural stability in people with multiple sclerosis: study protocol for a prospective randomized clinical trial.
Loyd BJ, Fangman A, Peterson DS, Gappmaier E, et al · · 2019 · cited 15× · PMID 31179920 · DOI 10.1186/s12883-019-1353-z
Rehabilitation to Improve Gaze and Postural Stability in People With Multiple Sclerosis: A Randomized Clinical Trial.
Loyd BJ, Fangman A, Peterson DS, Gappmaier E, et al · · 2022 · cited 8× · PMID 36113117 · DOI 10.1177/15459683221124126

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other University of Utah trials

Trials by the same sponsor.

NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies · NA · not yet recruiting
NCT07225426 — Personalizing Financial Incentives · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers · NA · not yet recruiting
NCT04208984 — Diversion Device With Breath Control · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03521557 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 6 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03521557.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing